Welcome to our dedicated page for IBEX SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on IBEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into IBEX's regulatory disclosures and financial reporting.
IBEX Ltd (IBEX) received a Form 144/A notice reporting a planned resale of restricted common shares under Rule 144 for the account of officer David Martin Afdahl. The filing covers up to 17,500 common shares to be sold through RBC Capital Markets LLC on NASDAQ, with an aggregate market value of $649,008.00 based on the stated market price.
The shares to be sold were acquired from the issuer upon the vesting of restricted stock awards on December 31, 2018. The amendment notes it relates to the acquisition of shares that were sold and previously filed for a transaction dated September 8, 2026.
IBEX Ltd (IBEX) reported that its Chief Operating Officer, David Martin Afdahl, sold common shares in an open-market transaction. On September 8, 2026, he sold 17,500 common shares at a weighted average price of $37.0862 per share, pursuant to a Rule 10b5-1 trading plan dated June 8, 2026. Following this sale, he directly owns 140,006 common shares of IBEX Ltd.
IBEX Ltd (IBEX) reports solid growth for the year ended June 30, 2026, as its AI‑enabled customer experience and BPO platform expanded with approximately 140 clients and about 35,000 employees across 30 delivery centers in the U.S., Philippines, Jamaica, Nicaragua, Pakistan and Honduras.
Revenue rose to $644.1 million with income from operations of $55.0 million and net income of $46.3 million, while diluted EPS reached $3.13. Cash from operations strengthened to $59.0 million, supporting capital expenditures of $27.8 million and ongoing investments in the Wave iX AI platform and global sites. The balance sheet shows $32.6 million of cash, minimal debt (about $1.7 million of finance lease obligations), and stockholders’ equity of $170.2 million, alongside significant operating lease and purchase commitments totaling $90.2 million.
Management highlights a strategy centered on AI‑powered CX (“BPO 3.0”), a “land and expand” client model, and a largely offshore/nearshore footprint where 97% of on‑site capacity resides. Key risks include dependence on major clients, exposure to foreign currency movements (notably Philippine Peso, Jamaican Dollar and Pakistani Rupee), extensive lease obligations, potential future Bermuda corporate taxation once revenue exceeds €750 million, and possible dilution from a warrant granted to Amazon.
IBEX Ltd (IBEX) extended and expanded its credit facilities and reported record fiscal 2026 results with guidance for 2027. The U.S. Credit Agreement maturity was pushed to the earlier of October 22, 2029 or the Amended UAE Credit Agreement’s maturity, with a $25 million secured revolving facility subject to a 0.20% closing fee and a 0.30% annual commitment fee on the unused portion. In the UAE, Ibex Global FZ-LLC extended its facilities to October 22, 2029, kept a committed $50 million post-shipment seller revolving loan and a $50,000 credit card facility, added a $1 million performance bond facility, and granted a security interest over receivables up to $58.9 million.
For fiscal 2026, revenue rose 15.4% to $644.1 million, net income increased to $46.3 million, adjusted EBITDA to $82.4 million, and diluted EPS to $3.13, with free cash flow of $31.2 million and year-end net cash of $30.9 million. Guidance for fiscal 2027 calls for revenue of $700–$715 million and adjusted EBITDA of $90–$94 million, implying high-single to low-double-digit growth.
IBEX Ltd (IBEX) received a notice that company officer David Martin Afdahl plans to sell 17,500 shares of common stock under Rule 144. The planned sale, through RBC Capital Markets LLC, has an indicated aggregate market value of $649,008.00 and references 13,389,116 shares outstanding for this class.
The shares are tied to an ISO exercise dated June 30, 2020 and are to be sold on or after September 8, 2026 on NASDAQ pursuant to a Rule 10b5-1 trading plan established June 8, 2026.
American Century Investment Management, Inc., American Century Companies, Inc. and Stowers Institute for Medical Research report beneficial ownership of IBEX Limited common stock. Each reports beneficial ownership of 510,633 shares, representing 3.8% of the class as of June 30, 2026.
The reporting persons have sole voting power and sole dispositive power over these 510,633 shares, with no shared voting or dispositive power. The shares are held for various clients advised by American Century Investment Management, Inc., and no single client beneficially owns more than 5% of the class.
IBEX Ltd director Fiona Elizabeth Beck acquired 1,252 Common Shares on July 31, 2026 through performance-based stock units earned upon certification of performance goals for the period ending June 30, 2026. Following this award, she directly holds 14,835 Common Shares.
IBEX Ltd director Zhuang Mingzhe acquired 1,252 Common Shares on July 31, 2026 through the earning and conversion of performance-based stock units. These PSUs were earned when performance goals for the period ending June 30, 2026 were certified. After this equity award, Zhuang directly holds 8,335 Common Shares, reflecting compensation rather than an open-market purchase or sale.
IBEX Ltd director John William Jones acquired 1,353 Common Shares on July 31, 2026 at no cost, when previously granted performance-based stock units were earned upon certification of performance goals for the period ending June 30, 2026. After this conversion, he directly holds 16,597 Common Shares.
IBEX Ltd executive Bruce Neil Dawson, Chief Sales and CS Officer, earned and acquired 1,954 performance-based stock units that converted into Common shares on July 31, 2026 after performance for the period ending June 30, 2026 was certified. To satisfy related taxes, 855 shares were withheld by the company at $35.34 per share; no shares were sold by him to cover this tax liability.